medical device investing Chembio Diagnostics and LumiraDx Enter Collaboration to Develop New Point-of-Care Diagnostic Tests for Infectious Diseases
pharmaceutical investing Basilea licenses late-stage oncology drug candidate derazantinib from ArQule
medical device investing Chembio Diagnostics Reports Fourth Quarter and Full Year 2017 Financial Results
pharmaceutical investing Inovio and The Wistar Institute Receive More Than $4.6 Million in R&D Funding
Ezutromid Significantly Reduced Muscle Damage in DMD Patients in 24-Week Interim Data From Summit’s PhaseOut DMD Clinical Trial
Harvest Gold Identifies 15 Primary And 10 Secondary Targets For Its Diamond Drill Program At Its Mosseau Project In Quebec
HyProMag USA Receives "Make More in America" Domestic Finance Letter of Interest for up to US$92 Million From US EXIM Bank
Aston Bay and American West Metals Announce Drilling Preparations Underway at the Storm Project, Nunavut, Canada
